Regulus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.24%)
Regulus Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.2%)
Regulus Therapeutics | 10-Q:季度报表
Regulus Therapeutics | 8-K:Regulus Therapeutics公布2024年第三季度财务业绩和最新动态
Regulus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(6.24%)
Regulus Therapeutics | 8-K:重大事件
Regulus Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(6.2%)
Regulus Therapeutics | SC 13G:超过5%持股股东披露文件-Octagon Capital Advisors LP(6.5%),Ting Jia(6.5%)等
Regulus Therapeutics | 10-Q:2024财年二季报
Regulus Therapeutics | 8-K:Regulus Therapeutics公布2024年第二季度财务业绩和最新动态
Regulus Therapeutics | 4:持股变动声明-董事 Collier Kathryn J
Regulus Therapeutics | 8-K:重大事件
Regulus Therapeutics | 4:持股变动声明-董事 RASTETTER WILLIAM H
Regulus Therapeutics | 4:持股变动声明-董事 PAPADOPOULOS STELIOS
Regulus Therapeutics | 4:持股变动声明-董事 Witz Pascale
Regulus Therapeutics | 4:持股变动声明-董事 Rosen Hugh
Regulus Therapeutics | 4:持股变动声明-董事 Nunn Jason Raleigh
Regulus Therapeutics | 4:持股变动声明-高管 Aker Christopher Ray
Regulus Therapeutics | 4:持股变动声明-高管 CALSADA CRISPINA
Regulus Therapeutics | 4:持股变动声明-高管 Hagan Joseph P
暂无数据
暂无数据